« Previous Next » International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 1 , Pages 79-86 , 1 May 2008

A Phase III Study of Conventional Radiation Therapy Plus Thalidomide Versus Conventional Radiation Therapy for Multiple Brain Metastases (RTOG 0118)

Jonathan P.S. Knisely, M.D., F.R.C.P.C.
- Department of Therapeutic Radiology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
- Reprint requests to: Jonathan P. S. Knisely, M.D., F.R.C.P.C., Yale University School of Medicine and Yale Cancer Center, 333 Cedar Street, 133 HRT, P.O. Box 208040, New Haven, CT 06520-8040. Tel: (203) 785-2960; Fax: (203) 785-4622
Brian Berkey, M.S.
- Radiation Therapy Oncology Group, Philadelphia, PA
Arnab Chakravarti, M.D.
- Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Al W.K. Yung, M.D.
- Department of Neuro-Oncology and Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, TX
Walter J. Curran Jr., M.D.
- Department of Radiation Oncology, Emory University, Atlanta, GA
H. Ian Robins, M.D., Ph.D.
- Department of Human Oncology, University of Wisconsin Medical School, Madison, WI
- Department of Medicine, University of Wisconsin Medical School, Madison, WI
Benjamin Movsas, M.D.
- Department of Radiation Oncology, Henry Ford Health System, Detroit, MI
David G. Brachman, M.D.
- Department of Radiation Oncology, AZ Oncology Services and St. Joseph's Hospital, Phoenix, AZ
Randall H. Henderson, M.D., M.B.A.
- University of Florida Proton Therapy Institute, Jacksonville, FL
Minesh P. Mehta, M.D.
- Department of Medicine, University of Wisconsin Medical School, Madison, WI